Monovalent influenza A/Astrakhan/3212/2020-like (H5N8) virus vaccine with AS03 adjuvant system
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monovalent influenza A/Astrakhan/3212/2020-like (H5N8) virus vaccine with AS03 adjuvant system, covering 2025-02-20 to 2025-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults [Phase 1, Phase 2]